Target intelligence / Profile preview

LncRNA regulator of macrophage immunity 1 (LROMI1)

Target
LROMI1
Molecular classification
Long noncoding RNA (lncRNA), Regulatory non-protein-coding RNA
01

Overview

LncRNA regulator of macrophage immunity 1 (LROMI1; AC022816.1) is a long noncoding RNA identified as an important regulator of human macrophage immune functions. It is part of an NFκB-dependent lncRNA network that modulates macrophage responses by interacting with mRNA-processing proteins such as hnRNPs. The function of LROMI1 is defined by its ability to fine-tune immune activation in response to pathogens, coordinating transcriptional and post-transcriptional regulatory events essential for the innate immune response. LROMI1 does not encode a protein but acts as a scaffold or guide for molecular interactions that ultimately impact the phenotype and function of immune cells, particularly macrophages[2].

Other names
AC022816.1
02

Mechanism of action

Not applicable; there are currently no drugs targeting LROMI1. Mechanistically, LROMI1 functions by binding mRNA processing factors and influencing transcriptional pathways (e.g., NFκB-dependent regulation)[2].

03

Biological functions

Regulation of macrophage immune responseModulation of inflammatory signalingInteraction with mRNA processing factors (e.g., hnRNP proteins)Influence on NFκB-dependent pathways and immune signaling
04

Disease associations

InflammationInfectionImmune dysregulation (potentially implicated in autoimmune conditions and host-pathogen response)
05

Safety considerations

None reported; as with many lncRNAs, safety concerns for therapeutic targeting would include off-target immune modulation and dysregulation of normal macrophage functions

Beyond the preview

Go deeper on LncRNA regulator of macrophage immunity 1 (LROMI1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LncRNA regulator of macrophage immunity 1 (LROMI1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call